Stay updated with breaking news from Tim Lenihan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
M&L Healthcare is a family-owned investment fund founded by shipping tycoon Michael Kum and his wife Lynda. Read more at straitstimes.com.
01.11.2023 - LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that it has entered into a definitive ...
The Inari deal comes weeks after LimFlow won FDA premarket approval for its breakthrough system to treat chronic limb-threatening ischemia.
EQS Newswire / 18/09/2023 / 11:40 CET/CEST SINGAPORE - Media OutReach - 18 September 2023 - M&L Healthcare, in its first major MedTech investment, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of the LimFlow System - a revolutionary thera...
Revolutionary limb saving procedure set to benefit patients with Chronic Limb-Threatening Ischemia, typically caused by Type 2 DiabetesSINGAPORE - Media OutReach - 15 September...